Journal article
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases
Abstract
BACKGROUND: Fibroblast growth factor-23 (FGF-23) is associated with a range of cardiovascular and noncardiovascular diseases in conventional epidemiological studies, but substantial residual confounding may exist. Mendelian randomization approaches can help control for such confounding.
METHODS: SCALLOP Consortium data of 19,195 participants were used to generate an FGF-23 genetic score. Data from 337,448 UK Biobank participants were used to …
Authors
Donovan K; Herrington WG; Paré G; Pigeyre M; Haynes R; Sardell R; Butterworth AS; Folkersen L; Gustafsson S; Wang Q
Journal
Clinical Journal of the American Society of Nephrology, Vol. 18, No. 1, pp. 17–27
Publisher
Wolters Kluwer
Publication Date
January 2023
DOI
10.2215/cjn.05080422
ISSN
1555-9041